C.I. Falkson
Department of Medical Oncology
University of Pretoria
South Africa
Name/email consistency: high
- A phase II evaluation of clofazimine plus doxorubicin in advanced, unresectable primary hepatocellular carcinoma. Falkson, C.I., Falkson, G. Oncology (1999)
- Prognostic factors in metastatic malignant melanoma. An analysis of 236 patients treated on clinical research studies at the Department of Medical Oncology, University of Pretoria, South Africa from 1972-1992. Falkson, C.I., Falkson, H.C. Oncology (1998)
- Mitomycin C, epirubicin and cisplatin versus mitomycin C alone as therapy for carcinoma of unknown primary origin. Falkson, C.I., Cohen, G.L. Oncology (1998)
- Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Group study. Falkson, C.I., Ibrahim, J., Kirkwood, J.M., Coates, A.S., Atkins, M.B., Blum, R.H. J. Clin. Oncol. (1998)